secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2025-09-23T23:59:59+00:00
Accession:  0001493152-25-014652
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma shareholders elect all six directors, approve option repricing, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Keyser (2.21M for), Sharma (2.21M), Chandru (2.20M), Maccecchini (2.21M), Schalop (2.21M), Silberstein (2.21M); broker non-votes 5.19M.
- One-time repricing of stock options under 2018 Equity Incentive Plan approved: 1.46M for, 759K against, 30K abstain, 5.19M broker non-votes.
- Ratification of EisnerAmper LLP as auditor for FY2025 passed: 7.37M for, 44K against, 26K abstain; no broker non-votes on this item.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315225014652/0001493152-25-014652-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315225014652/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-014652

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer